{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:11Z","timestamp":1793059931489,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jcv.2026.106003","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:46:22Z","timestamp":1789688782000},"page":"106003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A decade of chronic hepatitis E treatment: Ribavirin effectiveness, safety, and the association of Torque Teno Virus load with treatment outcomes"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9252-2863","authenticated-orcid":false,"given":"G.","family":"Roo-Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-6744","authenticated-orcid":false,"given":"EAM","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4129-5234","authenticated-orcid":false,"given":"M.","family":"Knoester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-7373","authenticated-orcid":false,"given":"C.","family":"Van Leer-Buter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2026.106003_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4254\/wjh.v3.i12.285","article-title":"Epidemiology and prevention","volume":"3","author":"Teshale","year":"2011","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jcv.2026.106003_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2026.106003_bib3","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.cgh.2015.04.014","article-title":"Hepatitis E virus infection as a possible cause of acute liver failure in Europe","volume":"13","author":"Manka","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2026.106003_bib4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2026.106003_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","article-title":"Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis E virus infection after organ transplantation","volume":"89","author":"Kamar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2026.106003_bib6","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1111\/j.1600-6143.2012.04200.x","article-title":"Chronic hepatitis E in heart transplant recipients","volume":"12","author":"Pischke","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2026.106003_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2026.106003_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/ciz953","article-title":"Ribavirin for hepatitis E virus infection after organ transplantation: A large European retrospective multicenter study","volume":"71","author":"Kamar","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2026.106003_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1168400","article-title":"Understanding torquetenovirus (TTV) as an immune marker","volume":"10","author":"Gore","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jcv.2026.106003_bib10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/ajt.12253","article-title":"How should hepatitis E virus infection be defined in organ-transplant recipients?","volume":"13","author":"Kamar","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2026.106003_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jcv.2013.08.022","article-title":"The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period","volume":"58","author":"Riezebos-Brilman","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2026.106003_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.healun.2022.03.006","article-title":"High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients","volume":"41","author":"Hoek","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.jcv.2026.106003_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000001457","article-title":"Ribavirin for paramyxovirus infections in hematopoietic stem-cell transplant and lung transplant recipients: evaluation of an optimized dosing regimen","author":"Wilpshaar","year":"2026","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jcv.2026.106003_bib14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2026.106003_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2015.11.038","article-title":"Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity","volume":"74","author":"Nijskens","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2026.106003_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.jcv.2026.106003_bib17","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3201\/eid2108.150199","article-title":"Ribavirin for chronic hepatitis prevention among patients with hematologic malignancies","volume":"21","author":"Tavitian","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jcv.2026.106003_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/v8080222","article-title":"Treatment of HEV infection in patients with a solid-organ transplant and chronic hepatitis","volume":"8","author":"Kamar","year":"2016","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.jcv.2026.106003_bib19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cmi.2020.01.011","article-title":"Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors","volume":"26","author":"Focosi","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2026.106003_bib20","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/jac\/dkaf183","article-title":"Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic model","volume":"80","author":"Mulder","year":"2025","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:33:33Z","timestamp":1792661613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653226000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"alternative-id":["S1386653226000958"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2026.106003","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A decade of chronic hepatitis E treatment: Ribavirin effectiveness, safety, and the association of Torque Teno Virus load with treatment outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2026.106003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106003"}}